BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Pérez-Medina C, Teunissen AJP, Kluza E, Mulder WJM, van der Meel R. Nuclear imaging approaches facilitating nanomedicine translation. Adv Drug Deliv Rev 2020;154-155:123-41. [PMID: 32721459 DOI: 10.1016/j.addr.2020.07.017] [Cited by in Crossref: 19] [Cited by in F6Publishing: 20] [Article Influence: 9.5] [Reference Citation Analysis]
Number Citing Articles
1 Deng H, Li Xu, Ju J, Mo X, Ge G, Zhu X. Multifunctional nanoprobes for macrophage imaging. Biomaterials 2022. [DOI: 10.1016/j.biomaterials.2022.121824] [Reference Citation Analysis]
2 Li P, Wang D, Hu J, Yang X. The role of imaging in targeted delivery of nanomedicine for cancer therapy. Adv Drug Deliv Rev 2022;:114447. [PMID: 35863515 DOI: 10.1016/j.addr.2022.114447] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
3 Kaeokhamloed N, Legeay S, Roger E. FRET as the tool for in vivo nanomedicine tracking. J Control Release 2022;349:156-73. [PMID: 35779657 DOI: 10.1016/j.jconrel.2022.06.048] [Reference Citation Analysis]
4 He H, Zhang X, Du L, Ye M, Lu Y, Xue J, Wu J, Shuai X. Molecular imaging nanoprobes for theranostic applications. Adv Drug Deliv Rev 2022;186:114320. [PMID: 35526664 DOI: 10.1016/j.addr.2022.114320] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
5 Gawne PJ, Man F, Blower PJ, T M de Rosales R. Direct Cell Radiolabeling for in Vivo Cell Tracking with PET and SPECT Imaging. Chem Rev 2022. [PMID: 35549242 DOI: 10.1021/acs.chemrev.1c00767] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 6.0] [Reference Citation Analysis]
6 Chen X, Niu W, Du Z, Zhang Y, Su D, Gao X. 64Cu radiolabeled nanomaterials for positron emission tomography (PET) imaging. Chinese Chemical Letters 2022. [DOI: 10.1016/j.cclet.2022.02.070] [Reference Citation Analysis]
7 Yilmaz D, Sharp PS, Main MJ, Simpson PB. Advanced molecular imaging for the characterisation of complex medicines. Drug Discovery Today 2022. [DOI: 10.1016/j.drudis.2022.03.001] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
8 van Leent MMT, Priem B, Schrijver DP, de Dreu A, Hofstraat SRJ, Zwolsman R, Beldman TJ, Netea MG, Mulder WJM. Regulating trained immunity with nanomedicine. Nat Rev Mater. [DOI: 10.1038/s41578-021-00413-w] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 4.0] [Reference Citation Analysis]
9 Molkenova A, Atabaev TS, Hong SW, Mao C, Han D, Kim KS. Designing inorganic nanoparticles into computed tomography and magnetic resonance (CT/MR) imaging-guidable photomedicines. Materials Today Nano 2022. [DOI: 10.1016/j.mtnano.2022.100187] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
10 Cheng MHY, Overchuk M, Rajora MA, Lou JWH, Chen Y, Pomper MG, Chen J, Zheng G. Targeted Theranostic 111In/Lu-Nanotexaphyrin for SPECT Imaging and Photodynamic Therapy. Mol Pharm 2021. [PMID: 34965727 DOI: 10.1021/acs.molpharmaceut.1c00819] [Reference Citation Analysis]
11 Seniwal B, Thipe VC, Singh S, Fonseca TCF, Freitas de Freitas L. Recent Advances in Brachytherapy Using Radioactive Nanoparticles: An Alternative to Seed-Based Brachytherapy. Front Oncol 2021;11:766407. [PMID: 34900715 DOI: 10.3389/fonc.2021.766407] [Cited by in F6Publishing: 7] [Reference Citation Analysis]
12 Bonnet S, Elfatairi R, Franconi F, Roger E, Legeay S. Organic nanoparticle tracking during pharmacokinetic studies. Nanomedicine (Lond) 2021;16:2539-6. [PMID: 34814704 DOI: 10.2217/nnm-2021-0155] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
13 Chen L, Ge J, Huang B, Zhou D, Huang G, Zeng J, Gao M. Anchoring Group Mediated Radiolabeling for Achieving Robust Nanoimaging Probes. Small 2021;:e2104977. [PMID: 34651420 DOI: 10.1002/smll.202104977] [Cited by in F6Publishing: 4] [Reference Citation Analysis]
14 Díez-Villares S, Pellico J, Gómez-Lado N, Grijalvo S, Alijas S, Eritja R, Herranz F, Aguiar P, de la Fuente M. Biodistribution of 68/67Ga-Radiolabeled Sphingolipid Nanoemulsions by PET and SPECT Imaging. Int J Nanomedicine 2021;16:5923-35. [PMID: 34475757 DOI: 10.2147/IJN.S316767] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
15 Schrijver DP, Dreu A, Hofstraat SRJ, Kluza E, Zwolsman R, Deckers J, Anbergen T, Bruin K, Trines MM, Nugraha EG, Ummels F, Röring RJ, Beldman TJ, Teunissen AJP, Fayad ZA, Meel R, Mulder WJM. Nanoengineering Apolipoprotein A1‐Based Immunotherapeutics. Advanced Therapeutics 2021;4:2100083. [DOI: 10.1002/adtp.202100083] [Reference Citation Analysis]
16 Perrigue PM, Murray RA, Mielcarek A, Henschke A, Moya SE. Degradation of Drug Delivery Nanocarriers and Payload Release: A Review of Physical Methods for Tracing Nanocarrier Biological Fate. Pharmaceutics 2021;13:770. [PMID: 34064155 DOI: 10.3390/pharmaceutics13060770] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
17 Teunissen AJP, Burnett ME, Prévot G, Klein ED, Bivona D, Mulder WJM. Embracing nanomaterials' interactions with the innate immune system. Wiley Interdiscip Rev Nanomed Nanobiotechnol 2021;:e1719. [PMID: 33847441 DOI: 10.1002/wnan.1719] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
18 Saluja V, Mishra Y, Mishra V, Giri N, Nayak P. Dendrimers based cancer nanotheranostics: An overview. Int J Pharm 2021;600:120485. [PMID: 33744447 DOI: 10.1016/j.ijpharm.2021.120485] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
19 Bernal A, Calcagno C, Mulder WJM, Pérez-Medina C. Imaging-guided nanomedicine development. Curr Opin Chem Biol 2021;63:78-85. [PMID: 33735814 DOI: 10.1016/j.cbpa.2021.01.014] [Cited by in F6Publishing: 4] [Reference Citation Analysis]
20 Pellico J, Gawne PJ, T M de Rosales R. Radiolabelling of nanomaterials for medical imaging and therapy. Chem Soc Rev 2021;50:3355-423. [PMID: 33491714 DOI: 10.1039/d0cs00384k] [Cited by in Crossref: 10] [Cited by in F6Publishing: 41] [Article Influence: 10.0] [Reference Citation Analysis]
21 Silva F, Cabral Campello MP, Paulo A. Radiolabeled Gold Nanoparticles for Imaging and Therapy of Cancer. Materials (Basel) 2020;14:E4. [PMID: 33375074 DOI: 10.3390/ma14010004] [Cited by in Crossref: 2] [Cited by in F6Publishing: 11] [Article Influence: 1.0] [Reference Citation Analysis]